Abstract

Lung cancer is a highly heterogeneous disease. Cancer cells and cells within the tumor microenvironment together determine disease progression, as well as response to or escape from treatment. To map the cell type-specific transcriptome landscape of cancer cells and their tumor microenvironment in advanced non-small cell lung cancer (NSCLC), we analyze 42 tissue biopsy samples from stage III/IV NSCLC patients by single cell RNA sequencing and present the large scale, single cell resolution profiles of advanced NSCLCs. In addition to cell types described in previous single cell studies of early stage lung cancer, we are able to identify rare cell types in tumors such as follicular dendritic cells and T helper 17 cells. Tumors from different patients display large heterogeneity in cellular composition, chromosomal structure, developmental trajectory, intercellular signaling network and phenotype dominance. Our study also reveals a correlation of tumor heterogeneity with tumor associated neutrophils, which might help to shed light on their function in NSCLC.

Comprehensive profiles of tumour and microenvironment are critical to understand heterogeneity in non-small cell lung cancer (NSCLC). Here, the authors profile 42 late-stage NSCLC patients with single-cell RNA-seq, revealing immune landscapes that are associated with cancer subtype or heterogeneity.

Details

Title
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
Author
Wu, Fengying 1 ; Fan Jue 2 ; He Yayi 1 ; Xiong Anwen 1 ; Yu, Jia 1 ; Li, Yixin 2 ; Zhang, Yan 2 ; Zhao Wencheng 1 ; Zhou, Fei 1 ; Li, Wei 1 ; Zhang, Jie 1 ; Zhang, Xiaosheng 1 ; Qiao Meng 1 ; Gao Guanghui 1 ; Chen Shanhao 1 ; Chen, Xiaoxia 1 ; Li, Xuefei 1 ; Hou Likun 3 ; Wu, Chunyan 3 ; Su Chunxia 1 ; Ren Shengxiang 1 ; Odenthal Margarete 4   VIAFID ORCID Logo  ; Buettner, Reinhard 4   VIAFID ORCID Logo  ; Fang, Nan 2   VIAFID ORCID Logo  ; Zhou Caicun 1   VIAFID ORCID Logo 

 Tongji University School of Medicine, Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535) 
 Singleron Biotechnologies, Nanjing, China (GRID:grid.508212.c) 
 Tongji University School of Medicine, Department of Pathology, Shanghai Pulmonary Hospital, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535) 
 University Hospital of Cologne, Institute of Pathology, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X); University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2522237344
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.